British American Tobacco said that its U.S. indirect subsidiary, R. J. Reynolds Vapor Company, received Marketing Denial Orders for Vuse Alto’s Menthol and Mixed Berry products. Vuse Alto Rich Tobacco and Golden Tobacco products remain under review with FDA. R. J. Reynolds Vapor Company intends to challenge the denials and will seek a stay of enforcement of the Menthol denial immediately. “This decision flies in the face of proven science and is contrary to the FDA’s stated goal of reducing the health effects of tobacco use. This disappointing decision would harm, not benefit, public health. We believe appropriately regulated flavoured vaping products-including menthol-are critical in supporting adult smokers migrate from combustible cigarettes,” the company said in a statement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BTI:
- FDA denies marketing of six flavored Vuse Alto e-cigarette products
- FDA to ban Vuse menthol e-cigarette sales, WSJ reports
- Yielding 9.2%, British American Stock (NYSE:BTI) Looks Better Than Ever
- GCOW: An ETF for Dividend and Free Cash Flow Lovers
- TD Cowen puts $33 target on U.S. shares of British American Tobacco